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Different Colony-Stimulating Factors Are Detected by the
“Interleukin-3”-Dependent Cell Lines FDC-Pl and 32D cl-23
By Andrew J. Hapel, Hilary S. Warren, and David A. Hume
The cell lines FDC-Pl and 32D cl-23 have previously been
used as unique indicators for the growth-promoting activ-
ity of interleukin-3. We show that FDC-Pl cells respond to
granulocyte I macrophage colony-stimulating factor (GM-
CSF. CSF-2) as well as to interleukin-3. In keeping with this
finding, FDC-Pl cells express the macrophage-specific
marker, F4/80. FDC-Pl cells do not. however, respond to
macrophage CSF (M-CSF. CSF-1 ). In contrast. 32D cl-23
cells do not respond to GM-CSF and lack F4/80. Instead.
32D cl-23 cells respond to an as yet undefined factor in
C ONDITIONED MEDIUM from the myelomono-
cytic cell line, WEHI-3B, supports the growth
and differentiation of granulocytes, macrophages,
mast cells, red cells, megakaryocytes, and a series of
factor-dependent cell lines and may influence develop-
ment ofT cell precursors.’4 The molecules responsible
for these effects are not separable on the basis of size,
charge, or hydrophobicity. Thus, several groups pro-
pose the existence of a single multifunctional polypep-
tide, for which the terms interleukin-3, multi-CSF,
and burst-promoting activity have been suggested.
Interleukin-3/multi-CSF has been purified from
WEI-II-3B conditioned medium (CM) on the basis of
its ability to maintain the growth of the FDC-Pl
hemopoietic cell line’3 and from pokeweed mitogen-
stimulated spleen cell CM.4 FDC-Pl, and several other
nonmalignant cell lines with very divergent pheno-
types,5’6 are believed to be dependent solely on interleu-
kin-3 for growth.’ For FDC-Pl and 32D cl-23 cells, this
is not the case. We show that FDC-Pl cells, which were
originally derived from “Dexter” type bone marrow
culture,7 express the macrophage-specific marker F4/
8089 and respond to murine granulocyte-macrophage
colony-stimulating factor (G M-CS F, CS F-2)--a bio-
chemically distinct hemopoietic regulator.’#{176} 32D cl-23
cells, derived from retrovirus-infected bone marrow
cultures,6 are Lyt- I + and alcian blue positive, and are
therefore related to the basophil lineage. These cells
respond to an as yet undefined product of human and
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conditioned medium (CM) from the primate 1 cell line.
MLA-144, and CM from mitogen-stimulated human lym-
phocytes (HLCM). 32D cl-23 cells are Lyt-1 + . Both FDC-Pl
and 32D cl-23 cells consume interleukin-3, but only FDC P1
cells consume GM-CSF. Similarly, 32D cI-23. but not FDC-
P1. cells consume 32D cl-23 growth factor from MLA-144
CM and HLCM. lnterleukin-3-dependent cell lines must
therefore concurrently express different functional cell
surface receptors for a variety of biochemically distinct
growth factors.
primate T cells that has no effect on proliferation of
FDC-Pl cells.
MATERIALS AND METHODS
Factor-producing cell lines were maintained in RPMI 1640
supplemented with 10% fetal bovine serum. Conditioned media
(CM) were collected from the primate T cell line, MLA-144,” and
the murine WEHI-3B cell lines as spinner cultures reached 106 cells
per mL. L929 conditioned medium was collected from confluent
monolayer cultures.’2 Cells were removed by centrifugation and CM
filtered through O.2-M Millipore sterilization filters. Purified inter-
Ieukin-3 (IL-3) was made by published methods’3 that involve
sequential chromatography on DEAE cellulose at pH 7.2, phenyl-
Sepharose, hydroxyapatite, and high-pressure liquid chromatogra-
phy (HPLC) using a Syncopal C-I8 reverse phase column (250 x
4.1 mm), eluted with an acetonitrile gradient in trifluoroacetic acid,
pH 2.0. lL-3 activity detected by FDC-PI and 32D cI-23 cell growth
eluted at 37.2% acetonitrile. Active samples were pooled and exten-
sively dialyzed against RPMI 1640. Purified granulocyte/macro-
phage colony-stimulating factor (CSF-2),’#{176} granulocyte CSF,’4 and
multi-CSF (interleukin-3)4 were provided by Drs Metcalf, Nicola,
Cutler, Johnson, and Burgess of the Walter and Eliza Hall Institute
of Medical Research, Melbourne. GM-CSF was prepared by
sequential chromatography of postendotoxin lung conditioned
medium (which does not contain IL-3 activity) using calcium
phosphate gel, DEAE cellulose, concanavalin A-Sepharose, and
Ultrogel AcA 44. This resulted in approximately a 2,000-fold
purification.’0 G-CSF was purified by salting out chromatography,
chromatography on phenyl-Sepharose, and gel filtration on Bio-GeI
P-60 I mol/L acetic acid.’4 These procedures separate GM-CSF
from G-CSF activity. Human lymphocyte CM was made by
previously published methods.’#{176} Briefly, human tonsil lymphocytes
were incubated in phytohemagglutinin (P1-IA) for one hour at 37 #{176}C,
washed, and incubated in serum-free Delbecco’s modified Eagle’s
medium (DMEM) overnight at 37 oC.IS The preparation was free of
residual mitogen. Interleukin-2 activity was measured in a prolifera-
tion assay using Con-A-activated cells.’5 The preparation supported
growth ofcolonies of human bone marrow cells (CFU-C) in agar and
in liquid culture (Hapel et al, unpublished observations). The
FDC-Pl and 32D cl-23 cell lines were maintained in RPMI 1640
supplemented with 30% CM from WEHI-3B cells. Microassays
using these cells were performed by incubating serial twofold
dilutions of factor with 2 x l0 cells in 100 aL of RPMI (+ 10%
fetal bovine serum) overnight at 37 #{176}C.ultures were pulsed the
next day using 0.5 MCi [#{176}H]thymidine for six hours before harvesting
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cells onto glass fiber filters and determining incorporated label by
scintillation counting.
RESULTS
Phenotypic Characteristics oJFDC-Pl and 32D cl-23
Cells
Purified interleukin-3 maintains the growth of cell
lines that differ markedly in phenotype.6 The 32D
cl-23 line expresses the T lymphocyte-associated
marker Lyt- 1 6 FDC-P1 cells do not possess this anti-
gen (unpublished) and have previously been reported
to express phenotypic characteristics of granulocytes.7
We have used the macrophage-specific monoclonal
antibody F4/808’9 to further discriminate between the
two lines by indirect immunofluorescence. FDC-Pl is
F4/80+ and 32D cl-23 is not. F4/80 antigen is also
present on the WEHI-3 myelomonocytic cell line that
produces interleukin-3. Previous reports by Whetton
and Dexter’6 similarly indicate the presence of macro-
phage, but not lymphocyte, markers on FDC cell
lines.
Growth ofFDC-Pl Cells in CSF-2
The data in Fig 1 confirm that both FDC-Pl and
32D cl-23 respond to purified interleukin-3’3 from
WEHI-3 conditioned medium. Both also respond to a
purified factor with multiple colony-stimulating activi-
ties (multi-CSF) that is derived from pokeweed
mitogen spleen conditioned medium.4 However, in
contrast to previous reports,”3 the sensitivity of the
two cell lines to purified factors and the slopes of the
Fig 1 . Growth of 32D cl-23 (A) and FDC-Pl
(B) cells in different purified factors and condi-
tioned media. Indicator cells were seeded at
2 x 10’ in microtiter wells containing serial
twofold dilutions of factor in RPMI 1 640 sup-
plemented with 10% fetal calf serum. Cultures
were incubated overnight at 37 ‘C in a humidi-
fled 5% CO2 atmosphere and pulsed for six
hours with 0.5 .tCi rH]thymidine. Four sepa-
rate preparations of MLA-144 CM and HLCM
gave similar results. Assays using purified fac-
tors were reproduced at least ten times. (#{149})
lnterleukin-3’/multi-CSF; (0) CSF-2 (GM-
CSF)’; (0) 1929 CM (M-CSF. CSF-1 ); (A) HLCM;
(U) MLA-144 CM; (v) G-CSF’. Prime (‘) denotes
purified factor.
dose-response curves differ markedly (Fig 1 ). Inter-
leukin-3/multi-CSF is able to induce mixed colonies of
granulocyte and macrophages in soft agar.’4 As FDC-
P1 cells express F4/80 antigen, indicating a relation-
ship to the monocyte series, we formed the hypothesis
that their response to interleukin-3/multi-CSF may be
related to the granulocyte-macrophage colony-stimu-
Iating activity of this factor. As shown in Fig I,
FDC-Pl cells respond to CSF-2 purified from posten-
dotoxin lung conditioned medium.’#{176} The dose-
response curve parallels that of interleukin-3. The
response to CSF-2 is specific in that neither purified
granulocyte colony-stimulating factor’4 nor L cell con-
ditioned medium (a source of macrophage colony-
stimulating factor CSF-l’2) maintained growth of
FDC-Pl. FDC-Pl cells thus differ from purified pri-
mary bone marrow-derived macrophages, which
appear to respond preferentially to CSF-l and CSF-
2.’ These observations contradict the claim that FDC-
P1 is exclusively an interleukin-3-dependent cell line.’
Growth of32D cl-23 Cells in MLA and HLCM
Unlike FDC-Pl, 32D cl-23 cells do not respond to
CSF-2 (Fig I ). This result correlates with the observa-
tion that the majority of CSF-2 in mouse lymphokine
preparations can be separated from 32D cl-23 growth
activity.’ Neither FDC-Pl nor bone marrow-derived
macrophages (unpublished) respond to human sources
of CSF-2, such as mitogen-stimulated lymphocyte
conditioned medium’5 or giant cell tumor (GCT) con-
ditioned medium’8 (Fig I ). In contrast to their inability
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Fig 2. Depletion of 32D cI-23 growth activity from WEHI-3B
CM, MLA-144 CM. and HLCM. FDC-Pl or 32D cI-23 cells (10/mL)
were incubated for 1 6 hours at 37 ‘C in factor-containing medium.
The level of factor used was estimated at between 1 and 5
ED/mL. Control cultures contained cells alone or factor alone.
Supernatants were filtered using 0.2 s disposable filters (Micro-
flow 25. Flow Filtration Systems) and assayed for 32D cI-23
growth activity. (A) WEHI-3B CM; (B) HLCM; (C) MLA-144 CM.
(-#{149}--) Factor control; (---4-----) factor depleted using FDC-Pl
cells; ( #{149} ) factor depleted using 32D Cl-23 cells;
(------------------) background ± 3 SD. The results obtained using
purified interleukin-3 from WEHI-3B CM, or purified multi-CSF
from PWMS CM. were indistinguishable from those obtained with
crude WEHI-3B CM. indicating that WEHI-3B CM contains only one
factor active in these assays.
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to maintain FDC-Pl cells, conditioned media from
human (mitogen-stimulated tonsillar lymphocytes)
and primate (MLA-l44 T lymphocyte line”) lym-
phoid sources contain significant 32D cl-23 growth
factor activity (Fig 1 ). The dose-response curves for
these factors parallel that for interleukin-3 with a slope
of less than one.
Consumption ofDifferent Growth Factors by FDC-Pl
and 32D Cl-23 Cells
The results presented above demonstrate that two
interleukin-3-dependent cell lines differ markedly in
their growth factor requirements. Iscove et al,2 in
purifying burst-promoting activity (interleukin-3)
from WEHI-3B CM, comment that it remains possible
that there are several very closely related, but separate,
hemopoietic growth factors that copurify. To test
whether the two lines were responding to different
factors in CM from various sources, we attempted to
specifically deplete FDC-Pl and 32D cl-23 growth
factors by absorption. Both FDC-Pl and 32D cI-23
depleted WEH1-3 CM of growth factor activity for
either cell line. FDC-Pl cells depleted culture media of
purified CSF-2, but did not deplete 32D cl-23 growth
factor from human tonsil CM. Conversely, 32D cI-23
depleted human tonsil CM of its own growth factor
activity, but failed to deplete FDC-PI growth factor
from purified CSF-2 (Figs 2 and 3). Human tonsil CM
contains T cell growth factor or interleukin-2. The
absorption of growth factor activity from human tonsil
\
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Fig 3. Depletion of FDC-Pl growth activity from WEHI-3B CM
and purified granulocyte/macrophage CSF. Methods used were
similar to those described in Fig 2. (A) WEHI-3B CM; (B) granulo-
cyte/macrophage CSF. (----.--) Factor depleted using FDC-PI
cells; ( #{149} ) factor depleted using 32D cI-23 cells; (--)
factor control; (----- -) background ±  SD. Results
obtained using purified interleukin-3 from WEHI-38 CM. or pun-
fled multi-CSF from PWMS CM. were indistinguishable from those
obtained with crude WEHI-3B CM.
CM by 32D cl-23 cells was specific in that interleukin-
2 activity, detected by proliferation of T cell blasts,’5
was equally reduced by incubation with FDC-PI cells,
32D cl-23 cells, or in RPMI alone (data not shown).
DISCUSSION
F4/80 antigen has been shown to be a differentia-
tion antigen of mononuclear phagocytes.8’9 In cultures
of CSF- I -stimulated bone marrow, F4/80 is appar-
ently absent from pluripotent stem cells but is
expressed on nonadherent macrophage progenitors.’9
The expression of F4/80 on the FDC-Pl cell line,
which also has features of granulocytes,7”6 and on
WEHI-3 myelomonocytic cells, suggests that the
marker is expressed during differentiation of myelo-
monocytic hemopoietic cells prior to the bifurcation
between the monocyte and myeloid lineages. Both
CSF-2 and interleukin-3 induce the appearance of
nonadherent F4/80+ cells in cultures of adult bone
marrow (unpublished), and mature F4/80+ mono-
cytes respond to M-CSF (CSF- 1).12 FDC-Pl cells do
not respond to CSF-l (Fig 1). Further experiments will
be directed toward ascertaining whether FDC-PI cells
can be induced to express CSF- 1 receptors. Previous
reports have indicated that the presence of other
macrophage-specific markers on FDC lines is not
always associated with responsiveness to GM-CSF or
M-CSF.2#{176}A comparison of several FDC lines with
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different properties may therefore be a useful means of
establishing a developmental lineage for these cells.
An examination of the previous literature on inter-
leukin-3-dependent cell lines reveals that the choice of
lines for particular studies has been fortuitous. 32D
cI-23 was used to separate CSF-2 and interleukin-3
from mouse lymphokine preparations.’ FDC-Pl was
used in the purification of interleukin-3 from WEI-II-3
conditioned medium,’2 which does not contain CSF-2
(D. Metcalf, Walter and Eliza Hall Institute for
Medical Research, Melbourne, October 1983, per-
sonal communication). WEHI-3, rather than the lym-
phocyte line EL-4, which does produce CSF-2, was
used as a source of mRNA in the recent cloning of
eDNA for interleukin-3.2’
We have not yet characterized the human/primate
lymphokine that induces growth of 32D cl-23 cells ( Fig
1). Its failure to act on FDC-Pl cells suggests two
important facts. First, the human/primate analogs of
interleukin-3 and CSF-2, if they exist in our lympho-
kine preparations, do not interact with the mouse
receptors for these factors. Second, 32D cl-23, like
FDC-Pl, respond to at least two different growth
factors (both of which are probably present in mouse
lymphokine preparations) and cannot be used individ-
ually as a specific bioassay for interleukin-3. The
presence of Lyt-1 antigens on 32D cl-23 cells might
suggest the involvement of interleukin-2 (T cell growth
factor), but as human interleukin-2 interacts with
mouse T cells,’5 and mouse interleukin-2 is not active
on 32D cl-23 cells,’ interleukin-2 is an unlikely candi-
date. Furthermore, 32D cl-23 cells do not specifically
degrade interleukin-2. Alternatively, 32D cl-23 cells
have been shown to give rise to mast cell/basophil
colonies in soft agar,6 and human lymphokine prepara-
tions contain a factor that induces proliferation and
differentiation of mast cells.22 Purified interleukin-3
has been shown to have mast cell growth factor (P
cell-stimulating factor; histamine-producing cell-stim-
ulating factor) activity,’ but this does not preclude a
role for other factors in mast cell differentiation.
Further delineation of the function of human/primate
32D cl-23 growth factor awaits its purification and
molecular cloning of the mouse analog.
NOTE ADDED IN PROOF
It has been found that 32D cl-23 cells respond to
recombinant human interleukin-2 (provided by J. Far-
rar, Hoffman la Roche, Nutley, NJ) and to four
interleukin-2 species purified from HLCM by chroma-
tofocusing (A.J . Hapel, unpublished observations).
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